Medpace Holdings, Inc. - Related News

OtherPRNewsWire

Kuehn Law Encourages Investors of Medpace Holdings, Inc. to Contact Law Firm

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Medpace Holdings, Inc. (NASDAQ: MEDP) breached t

last month

OtherSeeking Alpha

Medpace: Cancellations Are Normalizing

Medpace Holdings demonstrates strong Q2 2026 net new business awards, with a 1.13x net book-to-bill and $3.0B backlog. Oncology bookings are robust, while cardiometabolic awards have declined; managem

2 months ago

EarningsSeeking Alpha

Medpace: 'Buy' On Financial Metric Improvements And Solid Q2 2026 Earnings

Medpace Holdings remains a "Buy" as Q2 2026 showed broad metric improvement and an inflection point in growth trajectory. The company's net book-to-Bill ratio rebounded to 1.13x, and backlog conversio

2 months ago

EarningsSeeking Alpha

Medpace Holdings, Inc. (MEDP) Q2 2026 Earnings Call Transcript

2 months ago